Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans

Cytotherapy

Volumn 8, Issue 5, 2006, Pages 427-436

  Peggs, K S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adaptive; Immune reconstitution; Innate; Transplantation

Indexed keywords

ALPHA INTERFERON; CD20 ANTIBODY; CD4 ANTIGEN; CD45 ANTIGEN; CD45RB ANTIGEN; CD8 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7; KERATINOCYTE GROWTH FACTOR; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD4 CD8 RATIO; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CLONING; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG DELIVERY SYSTEM; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGIC MALIGNANCY; HEMOGLOBINOPATHY; HORMONAL THERAPY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE DEFICIENCY; INNATE IMMUNITY; LYMPHOCYTE DEPLETION; MESENCHYME CELL; NATURAL KILLER CELL; NONHUMAN; OUTCOMES RESEARCH; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; STEM CELL MOBILIZATION; STROMA CELL; T LYMPHOCYTE;

GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNITY, INNATE; IMMUNITY, NATURAL; RECOVERY OF FUNCTION; TISSUE DONORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 33750190606     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240600851938     Document Type: Review

References (86)

1. Koehne, G and Zeller, W and Stockschlaeder, M and Zander, AR. (1997) Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation Bone Marrow Transplant, 19, pp. 149-56.
2. Kieper, WC and Troy, A and Burghardt, JT and (2005) Recent immune status determines the source of antigens that drive homeostatic T cell expansion J Immunol, 174, pp. 3158-63.
3. Michalek, J and Collins, RH and Hill, BJ and (2003) Identification and monitoring of graft-versus-host specific T-cell clone in stem cell transplantation Lancet, 361, pp. 1183-5.
4. Peggs, KS and Verfuerth, S and Pizzey, A and (2003) Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines Lancet, 362, pp. 1375-7.
5. Laylor, R and Dewchand, H and Simpson, E and Dazzi, F. (2005) Engraftment of allogeneic hematopoietic stem cells requires both inhibition of host-versus-graft responses and 'space' for homeostatic expansion Transplantation, 79, pp. 1484-91.
6. Chalandon, Y and Degermann, S and Villard, J and (2006) Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications Blood, 107, pp. 389-96.
7. Orsini, E and Alyea, EP and Chillemi, A and (2000) Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma Biol Blood Marrow Transplant, 6, pp. 375-86.
8. D'Sa, S and Peggs, K and Pizzey, A and (2003) T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions Br J Haematol, 123, pp. 309-22.
9. Bellucci, R and Alyea, EP and Weller, E and (2002) Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma Blood, 99, pp. 4610-17.
10. + T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy Blood, 89, pp. 3700-7.
11. Hakim, FT and Cepeda, R and Kaimei, S and (1997) Constraints on CD4 recovery postchemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells Blood, 90, pp. 3789-98.
12. + T cells constrains the TCR repertoire in healthy human adults Eur J Immunol, 35, pp. 1987-94.
13. Tayebi, H and Kuttler, F and Saas, P and (2001) Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells Exp Hematol, 29, pp. 458-70.
14. Oehler, VG and Radich, JP and Storer, B and (2005) Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia Biol Blood Marrow Transplant, 11, pp. 85-92.
15. Tayebi, H and Tiberghien, P and Ferrand, C and (2001) Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantation Bone Marrow Transplant, 27, pp. 167-75.
16. + T-lymphocyte regeneration after intensive chemotherapy N Engl J Med, 332, pp. 143-9.
17. Douek, DC and Vescio, RA and Betts, MR and (2000) Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution Lancet, 355, pp. 1875-81.
18. Douek, DC and McFarland, RD and Keiser, PH and (1998) Changes in thymic function with age and during the treatment of HIV infection Nature, 396, pp. 690-5.
19. Berzins, SP and Godfrey, DI and Miller, JF and Boyd, RL. (1999) A central role for thymic emigrants in peripheral T cell homeostasis Proc Natl Acad Sci USA, 96, pp. 9787-91.
20. Hazenberg, MD and Otto, SA and de Pauw, ES and (2002) T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events Blood, 99, pp. 3449-53.
21. Lewin, SR and Heller, G and Zhang, L and (2002) Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations Blood, 100, pp. 2235-42.
22. Weinberg, K and Blazar, BR and Wagner, JE and (2001) Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation Blood, 97, pp. 1458-66.
23. Storek, J and Joseph, A and Dawson, MA and (2002) Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation Transplantation, 73, pp. 1154-8.
24. Roux, E and Dumont-Girard, F and Starobinski, M and (2000) Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity Blood, 96, pp. 2299-303.
25. Hazenberg, MD and Verschuren, MC and Hamann, D and (2001) T cell receptor excision circles as markers for recent thymic emigrants: Basic aspects, technical approach, and guidelines for interpretation J Mol Med, 79, pp. 631-40.
26. Hakim, FT and Gress, RE. (2002) Reconstitution of thymic function after stem cell transplantation in humans Curr Opin Hematol, 9, pp. 490-6.
27. Klein, AK and Patel, DD and Gooding, ME and (2001) T-cell recovery in adults and children following umbilical cord blood transplantation Biol Blood Marrow Transplant, 7, pp. 454-66.
28. Storek, J and Dawson, MA and Storer, B and (2001) Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation Blood, 97, pp. 3380-9.
29. Robinet, E and Lapierre, V and Tayebi, H and (2003) Blood versus marrow hematopoietic allogeneic graft Transfus Apheresis Sci, 29, pp. 53-9.
30. Edinger, M and Hoffmann, P and Ermann, J and (2003) CD4(+)CD25(+) regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation Nat Med, 9, pp. 1144-50.
31. + regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia J Clin Invest, 112, pp. 1688-96.
32. + regulatory T cells Nat Med, 11, pp. 1238-43.
33. + regulatory T cells J Immunol, 171, pp. 5678-82.
34. Miura, Y and Thoburn, CJ and Bright, EC and (2004) Association of Foxp3 regulatory gene expression with graft-versus-host disease Blood, 104, pp. 2187-93.
35. + (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation Br J Haematol, 126, pp. 697-703.
36. + T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans Blood, 103, pp. 1140-6.
37. + T cells with graft-versus-host disease after donor lymphocyte infusions Haematologica, 90, pp. 1389-95.
38. Rezvani K, Mielke S, Ahmadzadeh M High donor Foxp3-positive regulatory T-cell (TREG) content is associated with a low risk of GVHD following HLA-matched allogeneic stem cell transplantation (SCT). Blood 2006. In press. (Apr 20. epub ahead of print.)
39. Shlomchik, WD and Couzens, MS and Tang, CB and (1999) Prevention of graft versus host disease by inactivation of host antigen-presenting cells Science, 285, pp. 412-15.
40. + T cells that survive irradiation regulate chronic graft-versus-host disease Blood, 104, pp. 1565-73.
41. Anderson, BE and McNiff, JM and Jain, D and (2005) Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: Requirements depend on target organ Blood, 105, pp. 2227-34.
42. Teshima, T and Ordemann, R and Reddy, P and (2002) Acute graft-versus-host disease does not require alloantigen expression on host epithelium Nat Med, 8, pp. 575-81.
43. Fearnley, DB and Whyte, LF and Carnoutsos, SA and (1999) Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation Blood, 93, pp. 728-36.
44. Auffermann-Gretzinger, S and Lossos, IS and Vayntrub, TA and (2002) Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients Blood, 99, pp. 1442-8.
45. Klangsinsirikul, P and Carter, GI and Byrne, JL and (2002) Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution Blood, 99, pp. 2586-91.
46. Chklovskaia, E and Nowbakht, P and Nissen, C and (2004) Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: Effects of endogenous flt3 ligand Blood, 103, pp. 3860-8.
47. Mohty, M and Gaugler, B and Faucher, C and (2002) Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation Hematology, 7, pp. 157-64.
48. Reddy, V and Iturraspe, JA and Tzolas, AC and (2004) Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease Blood, 103, pp. 4330-5.
49. Mohty, M and Blaise, D and Faucher, C and (2005) Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation Leukemia, 19, pp. 1-6.
50. Buggins, AG and Mufti, GJ and Salisbury, J and (2002) Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab Blood, 100, pp. 1715-20.
51. Ratzinger, G and Reagan, JL and Heller, G and (2003) Differential CD52 expression by distinct myeloid dendritic cell subsets: Implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation Blood, 101, pp. 1422-9.
52. Collin, MP and Hart, DN and Jackson, GH and (2006) The fate of human Langerhans cells in hematopoietic stem cell transplantation J Exp Med, 203, pp. 27-33.
53. Fry, TJ and Sinha, M and Milliron, M and (2004) Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution Blood, 104, pp. 2794-800.
54. Storek, J and Viganego, F and Dawson, MA and (2003) Factors affecting antibody levels after allogeneic hematopoietic cell transplantation Blood, 101, pp. 3319-24.
55. Ratanatharathorn, V and Ayash, L and Reynolds, C and (2003) Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody Biol Blood Marrow Transplant, 9, pp. 505-11.
56. Canninga-van Dijk, MR and van der Straaten, HM and Fijnheer, R and (2004) Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease Blood, 104, pp. 2603-6.
57. Gokmen, E and Raaphorst, FM and Boldt, DH and Teale, JM. (1998) Ig heavy chain third complementarity determining regions (H CDR3s) after stem cell transplantation do not resemble the developing human fetal H CDR3s in size distribution and Ig gene utilization Blood, 92, pp. 2802-14.
58. Bolan, CD and Leitman, SF and Griffith, LM and (2001) Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation Blood, 98, pp. 1687-94.
59. Griffith, LM and McCoy, JP, Jr and Bolan, CD and (2005) Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation Br J Haematol, 128, pp. 668-75.
60. Lapierre, V and Oubouzar, N and Auperin, A and (2001) Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantation Blood, 97, pp. 2580-6.
61. Morikawa, K and Miyawaki, T and Oseko, F and (1993) G-CSF enhances the immunoglobulin generation rather than the proliferation of human B lymphocytes Eur J Haematol, 51, pp. 144-51.
62. Ruggeri, L and Capanni, M and Casucci, M and (1999) Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation Blood, 94, pp. 333-9.
63. Ruggeri, L and Capanni, M and Urbani, E and (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science, 295, pp. 2097-100.
64. Savani, BN and Rezvani, K and Mielke, S and (2006) Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia Blood, 107, pp. 1688-95.
65. Shilling, HG and McQueen, KL and Cheng, NW and (2003) Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation Blood, 101, pp. 3730-40.
66. Shilling, HG and Young, N and Guethlein, LA and (2002) Genetic control of human NK cell repertoire J Immunol, 169, pp. 239-47.
67. Kolb, HJ and Mittermuller, J and Clemm, C and (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients Blood, 76, pp. 2462-5.
68. Andre-Schmutz, I and Le Deist, F and Hacein-Bey-Abina, S and (2002) Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: A phase 1/2 study Lancet, 360, pp. 130-7.
69. Amrolia PJ, Muccioli-Casadei G, Huls H Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplant. Blood 2006. In press. (Jun 1, epub ahead of print.)
70. Solomon, SR and Mielke, S and Savani, BN and (2005) Selective depletion of alloreactive donor lymphocytes: A novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation Blood, 106, pp. 1123-9.
71. Amrolia, PJ and Muccioli-Casadei, G and Yvon, E and (2003) Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses Blood, 102, pp. 2292-9.
72. Martins, SL and St John, LS and Champlin, RE and (2004) Functional assessment and specific depletion of alloreactive human T cells using flow cytometry Blood, 104, pp. 3429-36.
73. + T cells by virtue of their receptor beta loci sequences Proc Natl Acad Sci USA, 100, pp. 1180-4.
74. + T helper cells and hindered by naturally occurring T regulatory cells J Immunol, 174, pp. 2591-601.
75. Dudley, ME and Wunderlich, JR and Robbins, PF and (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science, 298, pp. 850-4.
76. Zhong, RK and Loken, M and Lane, TA and Ball, ED. (2006) CTLA-4 blockade by a human MAb enhances the capacity of AML-derived DC to induce T-cell responses against AML cells in an autologous culture system Cytotherapy, 8, pp. 3-12.
77. Stanislawski, T and Voss, RH and Lotz, C and (2001) Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer Nat Immunol, 2, pp. 962-70.
78. Rapoport, AP and Stadtmauer, EA and Aqui, N and (2005) Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer Nat Med, 11, pp. 1230-7.
79. Bozza, S and Perruccio, K and Montagnoli, C and (2003) A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation Blood, 102, pp. 3807-14.
80. Le Blanc, K and Rasmusson, I and Sundberg, B and (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells Lancet, 363, pp. 1439-41.
81. Le Blanc, K and Pittenger, M. (2005) Mesenchymal stem cells: Progress toward promise Cytotherapy, 7, pp. 36-45.
82. Nakamura, S and Otani, T and Ijiri, Y and (2000) IFN-gamma-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12 J Immunol, 164, pp. 3330-6.
83. Alpdogan, O and Hubbard, VM and Smith, OM and (2006) Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration Blood, 107, pp. 2453-60.
84. Alpdogan, O and Schmaltz, C and Muriglan, SJ and (2001) Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease Blood, 98, pp. 2256-65.
85. Sinha, ML and Fry, TJ and Fowler, DH and (2002) Interleukin 7 worsens graft-versus-host disease Blood, 100, pp. 2642-9.
86. Blazar, BR and McKenna, HJ and Panoskaltsis-Mortari, A and Taylor, PA. (2001) Flt3 ligand (FL) treatment of murine donors does not modify graft-versus-host disease (GVHD) but FL treatment of recipients post-bone marrow transplantation accelerates GVHD lethality Biol Blood Marrow Transplant, 7, pp. 197-207.